The results of the research supported by the RakFond by Bulatov E.R.
Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is a T-lymphocyte in which a gene encoding a CAR (chimeric antigen receptor) has been introduced ex vivo. Simplifying the concept, one can say that a T cell is a soldier of the regular troops, and a CAR-T cell is the special forces for performing highly complex tasks. An extracellular domain of the CAR provides recognition of the target tumor antigen (e.g. CD19), and an intracellular domain activates the mechanisms ...
ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH
PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING
Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA...
WHAT IS CLINICAL RESEARCH
RakFond's SAB Member Professor Nikolay Zhukov, MD, DSci, explains in this video what clinical research is, he describes different types of clinical studies, what they provide to medical doctors, and why taking part in clinical trials is important for patients...
NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II
Compiled by Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting...
NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I
The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting...
American Society of Clinical Oncology (ASCO) Issues the 14th Annual Report on Progress Against Cancer
ASCO’s Clinical Cancer Advances 2019 highlights the most significant clinical research advances of the past year and identifies priority areas where research efforts should be focused to accelerate progress against cancer...
2018 RESEARCH YEAR: ONCOLOGY NEWS
The area of oncology in 2018 was full of events and news, new studies results, some of them were practice-changing. Here we publish selected interesting news of this year...
MOTIVATION AND ROLE OF CLINICAL TRIALS FOR AN ONCOLOGIST’S SUCCESSFUL CLINICAL PRACTICE
By Timur Mitin, MD, PhD, Associate Professor of Radiation Medicine at Oregon Health and Science University, Medical Director of the Tuality/OHSU Cancer Center (Portland, USA).
Cancer statistics: incidence and mortality
This September the International Agency for Research on Cancer (IARC) issued the 2018 update of the GLOBOCAN – the online tool which contains data on incidence and mortality for 36 cancers in 185 countries...
